CHEMED CORPORATION

Analyst Reco. Chemed Corporation

Equities

CHE

US16359R1032

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
560.4 ^USD	-2.25%		-6.66%	-4.16%

Apr. 26	Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says	MT
Apr. 25	Transcript : Chemed Corporation, Q1 2024 Earnings Call, Apr 25, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Chemed Insider Sold Shares Worth $1,704,321, According to a Recent SEC Filing	Mar. 22	MT
Chemed Insider Sold Shares Worth $7,196,910, According to a Recent SEC Filing	Mar. 22	MT
RBC Boosts Price Target on Chemed to $712 From $604, Expects 'Strong' VITAS Momentum to Continue in 2024; Outperform Kept	Mar. 04	MT
Oppenheimer Raises Chemed Price Target to $650 From $625, Maintains Outperform Rating	Feb. 29	MT
Oppenheimer Adjusts Chemed Price Target to $625 From $590, Maintains Outperform Rating	Jan. 17	MT
RBC Raises Price Target on Chemed to $604 From $576, Keeps Outperform Rating	23-10-30	MT
RBC Cuts Price Target on Chemed to $576 From $610, Maintains Outperform Rating	23-07-31	MT
Oppenheimer Adjusts Chemed Price Target to $590 From $610, Maintains Outperform Rating	23-07-27	MT
RBC Boosts Price Target on Chemed to $610 From $587 After 'Solid Results,' Maintains Outperform Rating	23-05-01	MT
Oppenheimer Raises Chemed's Price Target to $610 From $580, Maintains Outperform Rating	23-04-28	MT
RBC Raises Price Target on Chemed to $587 From $545, Maintains Outperform Rating	23-02-27	MT
RBC Raises Price Target on Chemed to $545 From $541, Maintains Outperform Rating	22-11-03	MT
RBC Cuts Price Target on Chemed to $541 From $592, Citing Recent Industry Multiple Compression, Maintains Outperform Rating	22-08-01	MT
RBC Boosts Price Target on Chemed to $592 From $579, Maintains Outperform Rating	22-04-28	MT
RBC Cuts Price Target on Chemed to $579 From $609, Maintains Outperform Rating	22-03-04	MT
CHEMED : RBC Boosts Price Target on Chemed to $609 From $604, Citing Strong Roto-Rooter Growth, Maintains Outperform Rating	21-07-29	MT
CHEMED : RBC Boosts Price Target on Chemed to $604 From $600, Sees Guidance Raise Likely, Maintains Outperform Rating	21-05-10	MT
CHEMED : Oppenheimer Adjusts Chemed PT to $580 From $600, Maintains Outperform Rating	21-02-25	MT
CHEMED : Oppenheimer Adjusts Chemed's Price Target to $600 From $535, Maintains Outperform Rating	21-01-27	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer